Philips Warns Weaker Quarterly Sales, Profit Hit By Sleep Device Write-down
Koninklijke Philips NV (NYSE:PHG) said it expects third-quarter group sales to be approximately €4.3 billion with a comparable sales decline of…
Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests
Roche Holdings AG (OTC:RHHBY) has announced the launch of its next-generation portfolio of COVID-19 rapid antigen tests (2.0) for self-testing and…
With Meaningful Upside, This Cancer Stock Earns Analyst Upgrade
BMO Capital Markets upgraded Seagen Inc (NASDAQ:SGEN) from Market Perform to Outperform with a price target of $178 from $177, saying the…
Gilead’s Trodelvy Under FDA Review For Pre-Treated HR+/HER2- Metastatic Breast Cancer
The FDA has accepted for review Gilead Sciences Inc’s (NASDAQ:GILD) Trodelvy (sacituzumab govitecan-hziy) for unresectable locally advanced or metastatic hormone receptor…
FDA Highlights Quality Check Issues At Eli Lilly’s New Jersey Manufacturing Site
An inspection in July by the FDA revealed several issues surrounding quality control at Eli Lilly And Co's (NYSE: LLY) manufacturing site in Branchburg, NJ.
Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery
Illumina Inc (NASDAQ:ILMN) entered a strategic research collaboration with AstraZeneca plc (NASDAQ:AZN) on drug target discovery. Financial and other details of the partnership…
Cocrystal Pharma Advances One Of Its COVID-19 Antiviral Treatment Candidate
Cocrystal Pharma Inc (NASDAQ:COCP) selected CDI-988 for clinical development as an oral treatment for COVID-19. CDI-988 targeted a highly conserved…
A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading
Congressman Earl Blumenauer (D-Ore.) has served as the U.S. Representative for Oregon's 3rd congressional district since 1996.
Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing
Ginkgo Bioworks Holdings Inc (NYSE:DNA) collaborated with Merck & Co Inc (NYSE:MRK) to engineer up to four enzymes for use as biocatalysts in…
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.